Standards of Medical Care in Diabetes: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 7: | Line 7: | ||
====[[B. Diagnosis of Diabetes]]==== | ====[[B. Diagnosis of Diabetes]]==== | ||
====[[C. Categories of Increased Risk for Diabetes (Prediabetes)]]==== | ====[[C. Categories of Increased Risk for Diabetes (Prediabetes)]]==== | ||
==[[II. Testing for Diabetes in Asymptomatic Patients]]== | ==[[II. Testing for Diabetes in Asymptomatic Patients]]== | ||
| Line 12: | Line 13: | ||
====[[B. Screening for Type 2 Diabetes in Children]]==== | ====[[B. Screening for Type 2 Diabetes in Children]]==== | ||
====[[C. Screening for Type 1 Diabetes]]==== | ====[[C. Screening for Type 1 Diabetes]]==== | ||
==[[III. Detection and Diagnosis Of GDM]]== | ==[[III. Detection and Diagnosis Of GDM]]== | ||
==[[IV. Prevention/Delay Of Type 2 Diabetes]]== | ==[[IV. Prevention/Delay Of Type 2 Diabetes]]== | ||
==[[V. Diabetes Care]]== | ==[[V. Diabetes Care]]== | ||
| Line 50: | Line 54: | ||
====[[L. Bariatric Surgery]]==== | ====[[L. Bariatric Surgery]]==== | ||
====[[M. Immunization]]==== | ====[[M. Immunization]]==== | ||
==[[VI. Prevention and Management of Diabetes Complications]]== | ==[[VI. Prevention and Management of Diabetes Complications]]== | ||
| Line 73: | Line 78: | ||
::* ''[[Treatment]]'' | ::* ''[[Treatment]]'' | ||
====[[B. Nephropathy Screening and Treatment]]==== | ====[[B. Nephropathy Screening and Treatment]]==== | ||
:* '''[[Recommendations]]''' | :* '''[[Recommendations]]''' | ||
::* ''[[General Recommendations]]'' | ::* ''[[General Recommendations]]'' | ||
::* ''[[Screening]]'' | ::* ''[[Screening]]'' | ||
::* ''[[Treatment]]'' | ::* ''[[Treatment]]'' | ||
:* '''[[Assessment of Albuminuria Status and Renal Function]]''' | :* '''[[Assessment of Albuminuria Status and Renal Function]]''' | ||
====[[C. Retinopathy Screening and Treatment]]==== | ====[[C. Retinopathy Screening and Treatment]]==== | ||
| Line 91: | Line 94: | ||
::* ''[[Diabetic Autonomic Neuropathy]]'' | ::* ''[[Diabetic Autonomic Neuropathy]]'' | ||
:* '''[[Symptomatic Treatments]]''' | :* '''[[Symptomatic Treatments]]''' | ||
::* ''[[DPN]]'' | ::* ''[[DPN]]'' | ||
::* ''[[Treatment of Autonomic Neuropathy]]'' | ::* ''[[Treatment of Autonomic Neuropathy]]'' | ||
====[[E. Foot Care]]==== | ====[[E. Foot Care]]==== | ||
==[[VII. Assessment of Common Comorbid Conditions]]== | ==[[VII. Assessment of Common Comorbid Conditions]]== | ||
==[[VIII. Diabetes Care in Specific Populations]]== | ==[[VIII. Diabetes Care in Specific Populations]]== | ||
====[[A. Children and Adolescents]]==== | ====[[A. Children and Adolescents]]==== | ||
: '''[[1. Type 1 Diabetes]]''' | : '''[[1. Type 1 Diabetes]]''' | ||
:* '''[[a. Glycemic Control]]''' | :* '''[[a. Glycemic Control]]''' | ||
:* '''[[b. Screening and Management of Chronic Complications in Chilren and Adolescents With Type 1 Diabetes]]''' | :* '''[[b. Screening and Management of Chronic Complications in Chilren and Adolescents With Type 1 Diabetes]]''' | ||
| Line 118: | Line 121: | ||
====[[C. Older Adults]]==== | ====[[C. Older Adults]]==== | ||
====[[D. Cystic Fibrosis-Related Diabetes]]==== | ====[[D. Cystic Fibrosis-Related Diabetes]]==== | ||
==[[IX. Diabetes Care in Specific Settings]]== | ==[[IX. Diabetes Care in Specific Settings]]== | ||
| Line 129: | Line 133: | ||
: '''[[7. Bedside Blood Glucose Monitoring]]''' | : '''[[7. Bedside Blood Glucose Monitoring]]''' | ||
: '''[[8. Discharge Planning and DSME]]''' | : '''[[8. Discharge Planning and DSME]]''' | ||
====[[B. Diabetes and Employment]]==== | ====[[B. Diabetes and Employment]]==== | ||
====[[C. Diabetes and Driving]]==== | ====[[C. Diabetes and Driving]]==== | ||
====[[D. Diabetes Management in Correctional Institutions]]==== | ====[[D. Diabetes Management in Correctional Institutions]]==== | ||
==[[X. Strategies for Improving Diabetes Care]]== | ==[[X. Strategies for Improving Diabetes Care]]== | ||
Revision as of 20:33, 22 December 2013
|
Diabetes mellitus Main page |
|
Patient Information |
|---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karol Gema Hernandez, M.D. [2]
I. Classification and Diagnosis
A. Classification
B. Diagnosis of Diabetes
C. Categories of Increased Risk for Diabetes (Prediabetes)
II. Testing for Diabetes in Asymptomatic Patients
A. Testing for Type 2 Diabetes and Risk of Future Diabetes in Adults
B. Screening for Type 2 Diabetes in Children
C. Screening for Type 1 Diabetes
III. Detection and Diagnosis Of GDM
IV. Prevention/Delay Of Type 2 Diabetes
V. Diabetes Care
A. Initial Evaluation
B. Management
C. Glycemic control
- 1. Assessment of Glycemic Control
- 2. Glycemic Goals in Adults
D. Pharmacological and Overall Approaches to Treatment
- 1. Insulin Therapy for Type 1 Diabetes
- 2. Pharmacological Therapy for Hyperglycemia in Type 2 Diabetes
E. Medical Nutrition Therapy (MNT)
F. Diabetes Self-Management Education and Support
G. Physical Activity
- Frequency and Type of Exercise
- Evaluation of the Diabetic Patient Before Recommending An Exercise Program
- Exercise in the Presence of Nonoptimal Glycemic Control
- Hyperglycemia
- Hypoglycemia
- Exercise in the Presence of Specific Long-Term Complications of Diabetes
- Retinopathy
- Peripheral Neuropathy
- Albuminuria and Nephropathy
H. Psychosocial Assessment and Care
I. When Treatment Goals Are Not Met
J. Intercurrent Illness
K. Hypoglycemia
L. Bariatric Surgery
M. Immunization
VI. Prevention and Management of Diabetes Complications
A. CVD
- 1. Hypertension/blood pressure control
- 2. Dyslipidemia/Lipid Management
- 3. Antiplatelet Agents
- 4. Smoking Cessation
- 5. CHD Screening and Treatment
B. Nephropathy Screening and Treatment
C. Retinopathy Screening and Treatment
D. Neuropathy Screening and Treatment
E. Foot Care
VII. Assessment of Common Comorbid Conditions
VIII. Diabetes Care in Specific Populations
A. Children and Adolescents
- 1. Type 1 Diabetes
- 2. Type 2 Diabetes
- 3. Monogenic Diabetes Syndromes
B. Preconception Care
C. Older Adults
D. Cystic Fibrosis-Related Diabetes
IX. Diabetes Care in Specific Settings
A. Diabetes Care in the Hospital
- 1. Glycemic Targets in Hospitalized Patients
- 2. Antihyperglycemic Agents in Hospitalized Patients
- 3. Preventing Hypoglycemia
- 4. Diabetes Care Providers in the Hospital
- 5. Self-Management in the Hospital
- 6. MNT in the Hospital
- 7. Bedside Blood Glucose Monitoring
- 8. Discharge Planning and DSME